{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:14:54Z","timestamp":1761743694166},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T00:00:00Z","timestamp":1357171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s12020-012-9867-9","type":"journal-article","created":{"date-parts":[[2013,1,2]],"date-time":"2013-01-02T16:47:46Z","timestamp":1357145266000},"page":"403-410","source":"Crossref","is-referenced-by-count":19,"title":["Impact of incretin on early-phase insulin secretion and glucose excursion"],"prefix":"10.1007","volume":"44","author":[{"given":"Jie","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaofeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,3]]},"reference":[{"key":"9867_CR1","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.amjmed.2009.12.008","volume":"123","author":"RA DeFronzo","year":"2010","unstructured":"R.A. DeFronzo, Current issues in the treatment of type 2 diabetes. Overview of newer agents: where treatment is going. Am. J. Med. 123, S38\u2013S48 (2010)","journal-title":"Am. J. Med."},{"key":"9867_CR2","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","volume":"295","author":"L Monnier","year":"2006","unstructured":"L. Monnier, E. Mas, C. Ginet, F. Michel, L. Villon, J.P. Cristol, C. Colette, Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295, 1681\u20131687 (2006)","journal-title":"JAMA"},{"key":"9867_CR3","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1463-1326.2009.01160.x","volume":"12","author":"L Nalysnyk","year":"2010","unstructured":"L. Nalysnyk, M. Hernandez-Medina, G. Krishnarajah, Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature. Diabetes Obes. Metab. 12, 288\u2013298 (2010)","journal-title":"Diabetes Obes. Metab."},{"key":"9867_CR4","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1089\/dia.2008.0083","volume":"11","author":"D Tsujino","year":"2009","unstructured":"D. Tsujino, R. Nishimura, K. Taki, Y. Miyashita, A. Morimoto, N. Tajima, Daily glucose profiles in Japanese people with normal glucose tolerance as assessed by continuous glucose monitoring. Diabetes Technol. Ther. 11, 457\u2013460 (2009)","journal-title":"Diabetes Technol. Ther."},{"key":"9867_CR5","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.2337\/diacare.23.12.1830","volume":"23","author":"TS Temelkova-Kurktschiev","year":"2000","unstructured":"T.S. Temelkova-Kurktschiev, C. Koehler, E. Henkel, W. Leonhardt, K. Fuecker, M. Hanefeld, Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care 23, 1830\u20131834 (2000)","journal-title":"Diabetes Care"},{"key":"9867_CR6","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2337\/diabetes.47.6.859","volume":"47","author":"D Koya","year":"1998","unstructured":"D. Koya, G.L. King, Protein kinase C activation and the development of diabetic complications. Diabetes 47, 859\u2013866 (1998)","journal-title":"Diabetes"},{"key":"9867_CR7","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1365-2265.2011.04205.x","volume":"76","author":"C Wang","year":"2012","unstructured":"C. Wang, L. Lv, Y. Yang, D. Chen, G. Liu, L. Chen, Y. Song, L. He, X. Li, H. Tian, W. Jia, X. Ran, Glucose fluctuations in subjects with normal glucose tolerance, impaired glucose regulation and newly-diagnosed type 2 diabetes mellitus. Clin. Endocrinol. (Oxf.) 76, 810\u2013815 (2012)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"9867_CR8","first-page":"1252","volume":"87","author":"J Liu","year":"2007","unstructured":"J. Liu, Y.B. Li, H. Shao, Y.X. Li, Y.H. Yuan, Y.B. Xiao, J.P. Weng, Evaluation of islet beta cell function in subjects with normal glucose tolerance, impaired glucose regulation, and type 2 diabetes mellitus. Zhonghua Yi Xue Za Zhi 87, 1252\u20131255 (2007)","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"9867_CR9","first-page":"548","volume":"42","author":"TN Kim","year":"2012","unstructured":"T.N. Kim, M.S. Park, S.K. Lee, S.J. Yang, K.W. Lee, M.S. Nam, Y.S. Park, J.T. Woo, Y.S. Kim, S.H. Baik, Elevated A1C is associated with impaired early-phase insulin secretion rather than insulin resistance in Koreans at high risk for developing diabetes. Endocrine 42, 548\u2013591 (2012)","journal-title":"Endocrine"},{"key":"9867_CR10","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1053\/meta.2000.8623","volume":"49","author":"K Matsumoto","year":"2000","unstructured":"K. Matsumoto, H. Sakamaki, K. Izumino, M. Yano, Y. Ueki, S. Miyake, Y. Tominega, Increased insulin sensitivity and decreased insulin secretion in offspring of insulin-sensitive type 2 diabetic patients. Metabolism 49, 1219\u20131223 (2000)","journal-title":"Metabolism"},{"issue":"1\u20132","key":"9867_CR11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.2040-1124.2010.00022.x","volume":"1","author":"Y Seino","year":"2010","unstructured":"Y. Seino, M. Fukushima, D. Yabe, GIP and GLP-1, the two incretin hormones: similarities and differences. J. Diabetes Invest. 1(1\u20132), 8\u201323 (2010)","journal-title":"J. Diabetes Invest."},{"key":"9867_CR12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2337\/diabetes.50.3.609","volume":"50","author":"T Vilsb\u00f8ll","year":"2001","unstructured":"T. Vilsb\u00f8ll, T. Krarup, C.F. Deacon, S. Madesbad, J.J. Holst, Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. Diabetes 50, 609\u2013613 (2001)","journal-title":"Diabetes"},{"key":"9867_CR13","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1210\/jc.86.8.3717","volume":"86","author":"MB Toft-Nielsen","year":"2001","unstructured":"M.B. Toft-Nielsen, M.B. Damholt, S. Madsbad, L.M. Hilsted, T.E. Hughes, B.K. Michelsen, J.J. Holst, Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. J. Clin. Endocrinol. Metab. 86, 3717\u20133723 (2001)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9867_CR14","doi-asserted-by":"crossref","first-page":"749","DOI":"10.33549\/physiolres.931893","volume":"59","author":"J Skrha","year":"2010","unstructured":"J. Skrha, J. Hilgertov\u00e1, M. Jarol\u00edmkov\u00e1, M. Kunesov\u00e1, M. Hill, Meal test for glucose-dependent insulinotropic peptide (GIP) in obese and type 2 diabetic patients. Physiol. Res. 59, 749\u2013755 (2010)","journal-title":"Physiol. Res."},{"issue":"3","key":"9867_CR15","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/j.diabres.2010.06.004","volume":"89","author":"SJ Han","year":"2010","unstructured":"S.J. Han, H.J. Kim, S.E. Choi, Y. Kang, K.W. Lee, D.J. Kim, Incretin secretion and serum DPP-IV activity in Korean patients with type 2 diabetes. Diabetes Res. Clin. Pract. 89(3), e49\u2013e52 (2010)","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"3","key":"9867_CR16","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.bbrc.2010.01.134","volume":"393","author":"J Kozawa","year":"2010","unstructured":"J. Kozawa, K. Okita, A. Imagawa, J.J. Holst, K. Yamagata, I. Shimomura, Similar incretin secretion in obese and non-obese Japanese subjects with type 2 diabetes. Biochem. Biophys. Res. Commun. 393(3), 410\u2013413 (2010)","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"9867_CR17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00125-010-1896-4","volume":"54","author":"MA Narck","year":"2011","unstructured":"M.A. Narck, I. Vardarli, C.F. Deacon, J.J. Holst, J.J. Meier, Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes:what is up, what is down? Diabetologia 54, 10\u201318 (2011)","journal-title":"Diabetologia"},{"key":"9867_CR18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1507\/endocrj.K09E-269","volume":"57","author":"S Lee","year":"2010","unstructured":"S. Lee, D. Yabe, K. Nohtomi, M. Takada, R. Morita, Y. Seino, T. Hirano, Intact glucagon-like peptide-1 levels are not decreased in Japanese patients with type 2 diabetes. Endocr. J. 57, 119\u2013126 (2010)","journal-title":"Endocr. J."},{"key":"9867_CR19","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/j.diabres.2010.06.004","volume":"89","author":"SJ Han","year":"2010","unstructured":"S.J. Han, H.J. Kim, S.E. Choi, Y. Kang, K.W. Lee, D.J. Kim, Incretin secretion and serum DPP-IV activity in Korean patients with type 2 diabetes. Diabetes Res. Clin. Pract. 89, e49\u2013e52 (2010)","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"3","key":"9867_CR20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.2040-1124.2010.00078.x","volume":"2","author":"N Harada","year":"2011","unstructured":"N. Harada, A. Hamasaki, S. Yamane, A. Muraoka, E. Joo, K. Fujita, N. Inagaki, Plasma gastric inhibitory polypeptide and glucagon-like peptide-1 levels after glucose loading are associated with different factors in Japanese subjects. J. Diabetes Invest. 2(3), 193\u2013199 (2011)","journal-title":"J. Diabetes Invest."},{"key":"9867_CR21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s12020-011-9514-x","volume":"40","author":"B Laferrere","year":"2011","unstructured":"B. Laferrere, Do we really know why diabetes remits after gastric bypass surgery? Endocrine 40, 162\u2013167 (2011)","journal-title":"Endocrine"},{"issue":"3","key":"9867_CR22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF03346573","volume":"33","author":"E Mannucci","year":"2010","unstructured":"E. Mannucci, L. Pala, M. Monami, L. Da Vico, G. Bardini, I. Dicembrini, S. Ciani, C. Lamanna, N. Marchionni, C.M. Rotella, Glucagon-like peptide-1 response to meals and post-prandial hyperglycemia in type 2 diabetic patients. J. Endocrinol. Invest. 33(3), 147\u2013150 (2010)","journal-title":"J. Endocrinol. Invest."},{"issue":"11","key":"9867_CR23","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.1210\/jc.2005-1093","volume":"90","author":"F Fehse","year":"2005","unstructured":"F. Fehse, M. Trautmann, J.J. Holst, A.E. Halseth, N. Nanayakkara, L.L. Nielsen, M.S. Fineman, D.D. Kim, M.A. Nauck, Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes. J. Clin. Endocrinol. Metab. 90(11), 5991\u20135997 (2005)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"9867_CR24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s12020-011-9441-x","volume":"39","author":"KM Johnson","year":"2011","unstructured":"K.M. Johnson, T. Farmer, K. Schurr, E. Patrick Donahue, B. Farmer, D. Neal, A.D. Cherrington, Endogenously released GLP-1 is not sufficient to alter postprandial glucose regulation in the dog. Endocrine 39(3), 229\u2013234 (2011)","journal-title":"Endocrine"},{"issue":"1","key":"9867_CR25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.2040-1124.2011.00141.x","volume":"3","author":"D Yabe","year":"2012","unstructured":"D. Yabe, K. Watanabe, K. Sugawara, H. Kuwata, Y. Kitamoto, K. Sugizaki, S. Fujiwara, M. Hishizawa, T. Hyo, K. Kuwabara, K. Yokota, M. Iwasaki, N. Kitatani, T. Kurose, N. Inagaki, Y. Seino, Comparison of incretin immunoassays with or without plasma extraction: incretin secretion in Japanese patients with type 2 diabetes. J. Diabetes Invest. 3(1), 70\u201379 (2012)","journal-title":"J. Diabetes Invest."},{"issue":"10","key":"9867_CR26","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1210\/en.141.10.3710","volume":"141","author":"JT Lewis","year":"2000","unstructured":"J.T. Lewis, B. Dayanandan, J.F. Habener, T.J. Kieffer, Glucose-dependent insulinotropic polypeptide confers early phase insulin release to oral glucose in rats: demonstration by a receptor antagonist. Endocrinology 141(10), 3710\u20133716 (2000)","journal-title":"Endocrinology"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-012-9867-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-012-9867-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-012-9867-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T01:55:24Z","timestamp":1644026124000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-012-9867-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,3]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["9867"],"URL":"https:\/\/doi.org\/10.1007\/s12020-012-9867-9","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,3]]}}}